En­so­ma shut­ters Copen­hagen site from its Twelve Bio ac­qui­si­tion

Ge­nom­ic med­i­cines start­up En­so­ma is shut­ter­ing its Copen­hagen site and al­so elim­i­nat­ing “a very small num­ber” of roles at its Boston of­fice, a spokesper­son con­firmed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA